STOCK TITAN

Itron Inc 10-Q Filings

ITRI NASDAQ

Every 10-Q that Itron Inc (ITRI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ITRI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ITRI filings page.

Rhea-AI Summary

Itron, Inc. reported second-quarter 2026 revenue of $562.9 million, down from $606.8 million a year earlier, as lower product sales were partly offset by higher service revenue. Gross profit rose modestly to $230.6 million, and operating income was essentially flat at $76.1 million. A higher income tax provision lifted the effective tax rate to 33%, reducing net income attributable to Itron to $53.3 million (diluted EPS $1.19) from $68.3 million ($1.47) in the prior-year quarter.

For the first six months of 2026, revenue was $1.15 billion versus $1.21 billion in 2025, with net income of $106.7 million (diluted EPS $2.37) compared with $133.8 million ($2.89). Operating cash flow was strong at $173.6 million. Itron completed the $546.4 million acquisition of Locusview and continued integrating Urbint, boosting goodwill to $1.69 billion. To fund growth and retire earlier notes, the company issued $805 million of 2026 convertible notes, repaid $460 million of 2021 notes, and ended June with total debt of $1.61 billion and cash of $745.2 million. Share repurchases totaled $152.2 million in the first half, and a new $200 million buyback authorization was approved.

Rhea-AI Summary

Itron, Inc. reported quarterly revenue of $586.982 million, down from $607.151 million a year earlier, as lower product sales were partly offset by higher service revenue. Net income attributable to Itron was $53.459 million versus $65.474 million, with diluted EPS of $1.18 compared with $1.42.

Operating cash flow increased to $85.501 million, but cash and cash equivalents fell to $712.850 million from $1.020 billion, mainly due to acquisitions and financing actions. Itron completed the $546.6 million cash acquisition of Locusview and now reports a new Resiliency Solutions segment.

The company issued $805 million of new 2026 convertible notes, repaid $460 million of 2021 notes, and ended the quarter with total debt of $1.61 billion. It also repurchased about 1.05 million shares for $100 million, while total remaining performance obligations were about $2.0 billion, split roughly between the next 12 months and later periods.

Rhea-AI Summary

Itron, Inc. reported Q3 2025 results with total revenues of $581.6 million versus $615.5 million a year ago. Despite lower sales, gross profit rose to $219.5 million as product costs declined, lifting operating income to $81.8 million from $73.9 million.

Net income was $65.6 million and diluted EPS was $1.41, down from $1.70, largely reflecting a higher tax rate versus a favorable discrete benefit last year. For the first nine months, net income increased to $200.3 million and diluted EPS to $4.30 on stable cost control.

Cash and cash equivalents reached $1.33 billion, up from $1.05 billion at year-end, driven by $286.6 million in operating cash flow. Debt totaled $1.27 billion, with $458.9 million classified as current reflecting the 2021 convertible notes’ approaching maturity. The company entered a new $750 million revolving credit facility, with $704.9 million available at quarter-end. The quarter included a tax expense impact from the July 2025 tax law, while a subsequent event indicates a roughly $39 million tax benefit expected in Q4. Shares outstanding were 45,801,371 as of October 24, 2025.